Valley Wealth Managers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-175
Closed -$61.3K 338
2025
Q4
$61.3K Hold
175
﹤0.01% 208
2025
Q3
$56.5K Hold
175
﹤0.01% 202
2025
Q2
$68.1K Sell
175
-45,983
-100% -$18.5M ﹤0.01% 188
2025
Q1
$20.1M Buy
46,158
+5,809
+14% +$2.33M 1.52% 28
2024
Q4
$14.9M Buy
40,349
+2,846
+8% +$1.19M 1.11% 41
2024
Q3
$19.5M Buy
37,503
+52
+0.1% +$27.8K 1.45% 31
2024
Q2
$20.3M Sell
37,451
-2,502
-6% -$1.32M 1.62% 18
2024
Q1
$20.7M Sell
39,953
-1,692
-4% -$841K 1.56% 24
2023
Q4
$19.6M Buy
41,645
+65
+0.2% +$30.1K 1.53% 25
2023
Q3
$18.1M Sell
41,580
-605
-1% -$274K 1.51% 22
2023
Q2
$18.7M Sell
42,185
-894
-2% -$412K 1.68% 22
2023
Q1
$19.8M Sell
43,079
-371
-0.9% -$177K 1.8% 14
2022
Q4
$22.3M Sell
43,450
-1,385
-3% -$703K 2.07% 8
2022
Q3
$20.4M Sell
44,835
-1,517
-3% -$726K 2.03% 8
2022
Q2
$22.4M Sell
46,352
-2,297
-5% -$1.14M 2.09% 9
2022
Q1
$23.9M Sell
48,649
-1,739
-3% -$795K 2% 9
2021
Q4
$23.4M Sell
50,388
-1,857
-4% -$781K 1.87% 11
2021
Q3
$19.5M Sell
52,245
-956
-2% -$363K 1.7% 23
2021
Q2
$20.3M Sell
53,201
-2,399
-4% -$917K 1.72% 21
2021
Q1
$20M Sell
55,600
-1,010
-2% -$325K 1.79% 22
2020
Q4
$18.2M Sell
56,610
-4,499
-7% -$1.38M 1.78% 22
2020
Q3
$16.4M Sell
61,109
-1,128
-2% -$304K 1.81% 24
2020
Q2
$16.4M Sell
62,237
-2,872
-4% -$766K 1.83% 20
2020
Q1
$14.8M Sell
65,109
-1,146
-2% -$312K 1.92% 18
2019
Q4
$20M Sell
66,255
-71
-0.1% -$19.5K 2% 14
2019
Q3
$15.9M Sell
66,326
-191
-0.3% -$52.3K 1.69% 30
2019
Q2
$18.8M Buy
66,517
+3,038
+5% +$830K 1.99% 19
2019
Q1
$18.2M Sell
63,479
-8,175
-11% -$2.36M 1.99% 16
2018
Q4
$18.8M Sell
71,654
-3,363
-4% -$925K 2.46% 6
2018
Q3
$20.6M Sell
75,017
-5,606
-7% -$1.46M 2.43% 6
2018
Q2
$19.2M Sell
80,623
-3,117
-4% -$722K 2.34% 8
2018
Q1
$18.4M Sell
83,740
-1,682
-2% -$395K 2.24% 14
2017
Q4
$19.2M Sell
85,422
-5,854
-6% -$1.25M 2.31% 6
2017
Q3
$17.3M Sell
91,276
-515
-0.6% -$98K 2.18% 14
2017
Q2
$17.3M Sell
91,791
-1,679
-2% -$302K 2.31% 8
2017
Q1
$15.5M Sell
93,470
-2,302
-2% -$366K 2.05% 17
2016
Q4
$13.8M Sell
95,772
-1,311
-1% -$176K 1.97% 26
2016
Q3
$12.2M Buy
97,083
+3,730
+4% +$482K 1.79% 33
2016
Q2
$12.3M Buy
93,353
+3,623
+4% +$496K 1.87% 34
2016
Q1
$12.5M Buy
89,730
+3,175
+4% +$424K 2.11% 29
2015
Q4
$12.1M Buy
86,555
+773
+0.9% +$106K 2.17% 24
2015
Q3
$12M Buy
85,782
+3,536
+4% +$531K 2.19% 23
2015
Q2
$13.5M Sell
82,246
-6,592
-7% -$1.05M 2.35% 11
2015
Q1
$13.7M Sell
88,838
-4,195
-5% -$597K 2.36% 8
2014
Q4
$11.7M Buy
93,033
+424
+0.5% +$52.4K 2.09% 25
2014
Q3
$11.1M Sell
92,609
-2,260
-2% -$259K 2.12% 23
2014
Q2
$10.2M Sell
94,869
-1,270
-1% -$131K 1.94% 33
2014
Q1
$9.57M Sell
96,139
-414
-0.4% -$37.4K 1.91% 34
2013
Q4
$8.92M Sell
96,553
-4,944
-5% -$439K 1.83% 36
2013
Q3
$8.49M Sell
101,497
-1,134
-1% -$97.2K 1.85% 36
2013
Q2
$8.4M Buy
+102,631
New +$7.68M 1.9% 32

Other funds holding ELV

Valley Wealth Managers's ELV Position: Q1 2026 in Review

Valley Wealth Managers sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 175 shares — an estimated $61.3K sold.

Valley Wealth Managers first reported a position in ELV in Q2 2013 and held it in 51 quarters. The position peaked at $23.9M in Q1 2022. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Valley Wealth Managers reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Valley Wealth Managers sold 175 Elevance Health shares in Q1 2026, an estimated $61.3K.
  • Valley Wealth Managers first reported a position in Elevance Health in Q2 2013 and held it in 51 quarters.
  • Valley Wealth Managers's Elevance Health position peaked at $23.9M in Q1 2022.
  • 1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Valley Wealth Managers's 13F filing for Q1 2026, filed 6 May 2026.